Phase i trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: Translation from preclinical investigations aiming to improve the therapeutic ratio
- Aron Popovtzer
- , Daniel Normolle
- , Francis P. Worden
- , Mark E. Prince
- , Douglas B. Chepeha
- , Gregory T. Wolf
- , Carol R. Bradford
- , Theodore S. Lawrence
- , Avraham Eisbruch*
*Corresponding author for this work
- University of Michigan, Ann Arbor
- Rabin Medical Center Israel
- University of Pittsburgh
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations